Piperidinyl-morpholinyl derivatives as modulators of...

Details Piperidinyl-morpholinyl derivatives as modulators of... Piperidinyl-morpholinyl derivatives as modulators of...

2007-03-06

2007-03-06

McKane, Joseph K. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S129000, C544S141000

Reexamination Certificate

active

10486505

ABSTRACT:
The invention provides compounds of general formula (I), in which m, n, Z1, Z2, R1, R2, R3, R4and R5are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; and their use in therapy

REFERENCES:
patent: 4695575 (1987-09-01), Janssens et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5889006 (1999-03-01), Lowe et al.
patent: 5952349 (1999-09-01), Asberom et al.
patent: 5977138 (1999-11-01), Wang et al.
patent: 6066636 (2000-05-01), Kozlowski et al.
patent: 6387930 (2002-05-01), Baroudy et al.
patent: 6440440 (2002-08-01), Meerpoel et al.
patent: 6903115 (2005-06-01), Rigby et al.
patent: 0 099 139 (1984-01-01), None
patent: 121972 (1984-10-01), None
patent: 0 145 037 (1985-06-01), None
patent: 0 151 824 (1985-08-01), None
patent: 0 151 826 (1985-08-01), None
patent: 1 076 055 (2001-02-01), None
patent: 1250719 (1971-10-01), None
patent: WO 93/10091 (1993-05-01), None
patent: WO 95/08535 (1995-03-01), None
patent: WO 96/26196 (1996-08-01), None
patent: WO 96/34857 (1996-11-01), None
patent: WO 96/41631 (1996-12-01), None
patent: WO 97/24324 (1997-07-01), None
patent: WO 98/01425 (1998-01-01), None
patent: WO 98/05291 (1998-02-01), None
patent: WO 98/05292 (1998-02-01), None
patent: WO 98/06697 (1998-02-01), None
patent: WO 98/11128 (1998-03-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 99/37304 (1999-07-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 99/51578 (1999-10-01), None
patent: WO 00/00488 (2000-01-01), None
patent: WO 0012478 (2000-03-01), None
patent: WO 00/32590 (2000-06-01), None
patent: WO 00/35877 (2000-06-01), None
patent: WO 00/66559 (2000-11-01), None
patent: WO 01/02381 (2001-01-01), None
patent: WO 01/07436 (2001-02-01), None
patent: WO 01/29066 (2001-04-01), None
patent: WO 01/77101 (2001-10-01), None
patent: WO 01/92227 (2001-12-01), None
patent: WO 02/18335 (2002-03-01), None
patent: WO 02/20484 (2002-03-01), None
patent: WO 02/079190 (2002-10-01), None
patent: WO 02/081449 (2002-10-01), None
patent: WO 03/004487 (2003-01-01), None
patent: WO 03/024962 (2003-03-01), None
patent: WO 03/078395 (2003-09-01), None
patent: WO 03/078421 (2003-09-01), None
patent: WO 2004/029041 (2004-04-01), None
patent: WO 2004/085423 (2004-10-01), None
patent: WO 2004/087659 (2004-10-01), None
patent: WO 2004/099144 (2004-11-01), None
Hermans, B., et al., “4-Substituted Piperidines. II. Reaction of 1-Benzyl-4-cyano-4-t-aminopiperidines with Organometallic Compounds,” J. Med. Chem., vol. 8(6), pp. 851-855-(Nov. 1965), at p. 852 (“compound 12” in Table I).
Allain et al, (2005) STN International, HCAPLUS Database, Columbus, OH, Accession No. 1992:187881, Reg. No. 46817-91-8, citing “Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline,” Psychopharmacology, 106(Suppl.).
Cohen et al.,Am. J. Clin. Pathol.105:589 (1996).
Patani and LaVoie, “Bioisosterism: A Rational Approach in Drug Design”,Chem. Rev.96:3147-3176 (1996).
STN International, File CAPLUS, CAPLUS accession no. 1988:630911, Document no. 109:230911, Lehmann, Jochen et al: “Lactones. XVIII. Synthesis of lactone-bridged 1,1-diarylpropanamines”; &Arch. Pharm.(Weinheim, Ger.) (1988), 321(7), 443-445.

Affiliated with

Also associated with

Rating

Piperidinyl-morpholinyl derivatives as modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidinyl-morpholinyl derivatives as modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidinyl-morpholinyl derivatives as modulators of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3755215